SCHEMBL23947719

SCHEMBL23947719

Cc1sc2nc(C3CC3)nc(N3CCN(C(=O)CCl)CC3)c2c1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
HPGD P15428 5/20 0.59
LMNA P02545 5/20 0.54
ALOX15 P16050 2/20 0.54
ALDH1A1 P00352 7/20 0.49
MAPT P10636 6/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
NOD2 Q9HC29 1/20 0.49
KDM4E B2RXH2 4/20 0.48
HTT P42858 3/20 0.48
NPSR1 Q6W5P4 3/20 0.48
POLB P06746 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ATM Q13315 1/20 0.48
RECQL P46063 2/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29763673 1.00 MEN1 (0.61) MEN1KMT2AHPGDLMNAALOX15
SCHEMBL29763651 0.76 ALDH1A1 (0.57) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL23947721 0.76 ALDH1A1 (0.57) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL23947764 0.72 MEN1 (0.56) MEN1KMT2AHPGDLMNAALDH1A1
SCHEMBL23947741 0.67 ACACA (0.74) MEN1KMT2AHPGDLMNAALOX15
SCHEMBL29763665 0.67 ACACA (0.74) MEN1KMT2AHPGDLMNAALOX15
SCHEMBL14964997 0.65 KDM4E (0.47) MEN1KMT2AHPGDLMNAALOX15
SCHEMBL23947718 0.64 MEN1 (0.86) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL29763649 0.64 MEN1 (0.86) MEN1KMT2ALMNAALDH1A1MAPT
SCHEMBL23947763 0.64 MEN1 (0.75) MEN1KMT2AHPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047626-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY 2023-02-16 US disclosed
US-20220142973-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY 2022-05-12 US disclosed
WO-2021212010-A2 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS THE TRUSTEES OF INDIANA UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047626-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS TP53, EIF2AK2, POLI MEN1 3618/4885KMT2A 3300/4885HPGD 962/4885
US-20220142973-A1 SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS TP53, EIF2AK2, POLI MEN1 3618/4885KMT2A 3300/4885HPGD 962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.